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Case presentation
A 26-year-old woman was transferred to New England Medical
Center (NEMC) from another hospital with a diagnosis of acute renal
failure complicating antepartum hemorrhage, abruptio placentae, and
shock. Emergency Caesarean section delivered a stillborn child 2 days
prior to transfer. Postoperatively, the patient developed hypotension,
oozing from the surgical site that required multiple transfusions, and
acute oliguria. At NEMC, the patient remained oliguric for 16 days and
was virtually anuric for the first 10 days; the 24-hr urine volumes
averaged less than 50 cc. An abdominal x-ray revealed an 11.5-cm right
kidney and a 12.5-cm left kidney. The BUN and serum creatinine levels
rose as high as 128 and 18.9 mgldl. Hemodialysis was performed on
three occasions during the period of oligoanuria. The urine output
subsequently increased to a high of 1900 ml by the 29th hospital day.
The patient was discharged 5 weeks after admission with a serum
creatinine of 12.6 mg/dl.
Over the next 6 months, the serum creatinine gradually declined to
4.9 mg/dl. Nine months after the episode of acute renal failure,
percutaneous renal biopsy yielded only medullary tissue with nonspe-
cific degenerative changes, a marginal focus of necrosis, and numerous
protein casts. At this time, abdominal x-ray showed a 10-cm right
kidney and an 11-cm left kidney. Over the next 3 years, the serum
creatinine continued to decline gradually and finally reached 4.0 mgldl.
During this period, urinary protein excretion ranged between 0.5 and 2
g/day. During this 3-year period, the patient also developed hyperten-
sion and was treated for the next 5 years with 750 mg/day of methyldo-
pa. In addition she had recurrent episodes of right-sided paresthesias
and blurred vision that resolved following the discontinuation of oral
contraceptives. After she stopped taking the oral contraceptive, she
developed amenorrhea and galactorrhea. Evaluation revealed low lev-
els of FSH activity consistent with partial pituitary destruction; this
problem presumably was sustained in the immediate postpartum
period.
After maintaining stable renal function (the serum creatinine was
approximately 4.0 mgldl) for another 4 years (years 4 through 8 after the
episode of acute renal failure), the serum creatinine slowly rose over the
ensuing 7 years. Hypertension returned, concomitant with the further
decline in renal function, and again was treated with methyldopa.
During this period, 24-hr urinary protein excretion varied from 0.5 to
1.2 g. Uremic symptoms developed when the serum creatinine reached
8.7 mg/dl, 15 years after the acute postpartum renal failure, and chronic
ambulatory peritoneal dialysis was initiated.
Discussion
DR. BARRY M. BRENNER (Samuel A. Levine Professor of
Medicine, Harvard Medical School, and Director, Renal Divi-
sion, Brigham and Women's Hospital, Boston, Mass.): This
woman developed severe acute renal failure in the immediate
antepartum period in association with abruptio placentae, mas-
sive intrauterine hemorrhage, and cardiovascular collapse. She
became profoundly oliguric and required several hemodialysis
treatments before experiencing partial return of renal function.
This pattern of incomplete recovery of renal function after an
episode of massive peripartum hemorrhage secondary to abrup-
tio placentae is characteristic of the lesion of acute, bilateral,
renal cortical necrosis. Numerous reports emphasizing the
association of peripartum hemorrhage with bilateral renal corti-
cal necrosis have appeared since the initial description by
Bradford and Lawrence in 1898 [1]. In several of the patients
reported, organs other than the kidneys also were injured as a
consequence of the severe cardiovascular collapse, including
the anterior pituitary, liver, spleen, adrenal glands, and pancre-
as, with the anterior pituitary and adrenals being particularly
susceptible. In the patient under consideration today, amenor-
rhea and galactorrhea were recognized after a latent period of
several years; these sequelae probably reflected a mild form of
Sheehan's syndrome.
A number of excellent reviews have considered the well-
established clinical and pathologic features of bilateral renal
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cortical necrosis [2—5]. Rather than reiterate this information, I
instead would like to devote my discussion to the clinical
outcome of this patient's renal failure. Specifically, we are told
that renal function improved slowly and incompletely after her
acute illness, and that the serum creatinine concentration
declined to 4.9 mg/dl at 6 months and reached a nadir of 4.0
mgldl at 3 years. Renal function remained relatively stable at
this compromised level for the next 4 years. Not only does the
persistent azotemia connote a marked loss of nephron number,
but the presence of proteinuria during this interval indicates
that surviving glomeruli were abnormal as well. Not surprising-
ly, her renal function deteriorated progressively in association
with hypertension, and necessitated the initiation of chronic
dialysis.
Prior to the availability of dialysis, early death from uremia
was the usual outcome in patients with severe bilateral cortical
necrosis. In the past three decades, however, control of hyper-
kalemia, metabolic acidosis, circulatory congestion, and the
symptoms of uremia by conservative and dialytic management
has enabled such patients to survive the typically protracted
oligoanuric period seen in this disorder, which often extends for
several weeks beyond that usually noted in patients suffering
from the more commonplace entity of acute tubular necrosis.
Whereas patients with acute tubular necrosis experience a
relatively prompt return of renal function to near-normal levels
within days to a few weeks following the onset of diuresis, renal
function rarely recovers fully in patients with extensive renal
cortical necrosis. This loss of function reflects the permanent
nephron destruction that takes place in the areas of necrosis. In
the latter cases, creatinine clearances typically rise from ex-
tremely low levels during the oligoanuric period to values
approaching 10 to 15 mI/mm after 3 to 6 months, and peak at 20
to 30 mI/mm after I to 3 years [4]. It is generally assumed that
this slowly progressive improvement in overall renal function
results from the functional and structural hypertrophy of the
nephrons that escape the initial vascular damage, with juxtame-
dullary glomeruli and tubules being the least affected. Unfortu-
nately, many patients fail to sustain even these modest levels of
glomerular filtration rate; after a variable interval of relative
functional stability, GFR again declines, usually in association
with overt proteinuria and hypertension [4, 6, 7].
Until recently, no satisfactory explanation was available to
account for the eventual deterioration of renal function ob-
served so commonly in this patient population, although factors
such as hypertension, subsequent pregnancy, and progressive
interstitial fibrosis have been suggested. I believe that the
progression to end-stage renal disease in bilateral cortical
necrosis is a predictable, long-term hemodynamic consequence
of the initial loss of nephron mass induced by widespread and
irreversible ischemic renal injury. Indeed, such hemodynami-
cally mediated progression to end-stage renal failure is not
unique to this form of renal vascular injury, but may be a final
common pathway in a host of renal disorders characterized by
irreversible reduction in the number of functioning nephron
units.
Evidence for hemodynamicallv mediatedchronic renal
jflj,y in animals
Let me develop this hypothesis by citing some relevant
experimental evidence obtained in animals. As is well known,
when renal mass is reduced, the remaining nephrons undergo
functional as well as structural hypertrophy. Adaptations in the
microcirculation of remnant glomeruli result in an increased
mean driving force for filtration and, therefore, a marked
increase in single-nephron glomerular filtration rate (SNGFR)
[8, 91. The magnitude of this increase in SNGFR correlates
closely with the amount of renal mass that has been lost; that is,
greater degrees of ablation result in greater increases in SNGFR
in the residual glomeruli [8—101. This adaptive hyperfiltration in
surviving glomeruli generally is regarded as beneficial because
it minimizes the reduction in total GFR that otherwise would
ensue.
A growing body of evidence, suggests, however, that single-
nephron hyperfiltration—or some hemodynamic determinant(s)
thereof—may eventually prove injurious to the structural and
functional integrity of residual glomeruli [9, 11—14]. Fifty years
ago Chanutin and Ferris recognized that removal of approxi-
mately three-fourths of the total renal mass in the rat led to a
syndrome of progressive azotemia, proteinuria, and glomerular
sclerosis [15]. Shimamura and Morrison documented the pro-
gression of glomerular damage in adult rats subjected to surgical
resection of approximately 90% of total renal mass [11]. The
rats manifested an increase in glomerular size within 3 months,
and this increase was accompanied by ultrastructural alter-
ations, which included vacuolization of glomerular epithelial
cells and effacement of foot processes. By 6 months, expansion
of mesangial matrix and denudation of cells from areas of
glomerular basement membrane heralded progressive hyalini-
zation and ultimately sclerosis of these remnant glomeruli.
Studies employing unilateral nephrectomy and infarction of
approximately three-fifths of the remaining kidney revealed
morphologic changes similar to those deriving from extensive
surgical ablation [12]. With somewhat more severe reductions
in renal mass induced by uninephrectomy and infarction of
approximately five-sixths of the remaining kidney, Olson et al
observed similar structural disruption but at an accelerated
pace; morphologic abnormalities were evident in remnant gb-
meruli at one week after the ablative procedure [13]. At that
time, gbomerular endothelial and epithelial cells were detached
from the adjacent basement membrane in a focal manner.
Protein reabsorption droplets were visible in both glomerular
epithelial and mesangial cells, and mesangial volume was
increased.
Proteinuria also develops following renal ablation; most rats
subjected to high-grade nephrectomy eventually excrete several
hundred milligrams of protein per day as compared to less than
10 milligrams per day in control animals [111. Olson and
coworkers documented a fourfold increase in protein excretion
in rats only one week after unilateral nephrectomy and infarc-
tion of approximately five-sixths of the remaining kidney [13].
This level of protein excretion is especially noteworthy in view
of the fact that the total GFR for the remnant kidney was only
15% to 20% of the value for both kidneys in control rats. Thus,
factored for GFR, protein excretion was more than 20-fold
greater in experimental than in control animals.
In an effort to further characterize this acquired defect in
permselectivity, Olson and coworkers evaluated the processing
of tracer macromolecules after severe reduction in renal mass
[13]. Relative to values in control animals, glomerular filtration
of uncharged macromolecules, as assessed by the fractional
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clearance of neutral dextrans, was not altered for dextrans with
molecular radii in the range between 20 and 38 A. Fractional
clearance values for neutral dextrans larger than 38 A were
increased significantly in remnant glomeruli, however. This
finding indicated partial disruption of the size-selective proper-
ties of the glomerular capillary wall. Such a defect is in keeping
with the findings of Robson and colleagues, who demonstrated
an increase in the fractional clearance of another neutral
polymer, polyvinylpyrrolidone, in rats subjected either to sub-
total nephrectomy or unilateral pyelonephntis [16].
When the charge-selective properties of the glomerular wall
were probed using both negatively charged dextrans and vari-
ously charged molecules of horseradish peroxidase, a defect in
the ability to restrict negatively charged macromolecules also
was apparent [131. In short, remnant glomeruli lose both size-
and charge-selectivity, and these alterations account for the
progressive proteinuria that occurs after loss of renal mass.
Based on recently acquired data from our laboratory [8, 9, 13,
14, 17—201, we have suggested that the syndrome of progressive
azotemia, proteinuria, and glomerular sclerosis occurring with
renal ablation is due to sustained elevations in glomerular
capillary pressures and flows. In our initial study, SNGFR and
its hemodynamic determinants were measured in remnant gb-
meruli one week following right nephrectomy and infarction of
approximately five-sixths of the left kidney in Munich-Wistar
rats [9]. Values for SNGFR in partially nephrectomized rats
averaged 63 nI/mm, more than twice the mean value of 28 nI/mm
of sham-operated control rats. This marked increment in
SNGFR 1 week after ablation was due mainly to significant
changes in two factors: (1) Glomerular capillary plasma flow
rate (QA) was elevated on average to 187 nl/min compared to 74
ni/mm in controls; and (2) Mean glomerular transcapillary
hydraulic pressure difference (P) averaged 44 mm Hg, as
compared to the control value of 37 mm Hg. No meaningful
differences in the remaining two determinants of SNGFR,
namely, systemic oncotic pressure or glomerular capillary
ultrafiltration coefficient, emerged in these studies.
To ascertain whether these increments in pressures and flows
constitute the basis for eventual damage to remnant glon-ieruli,
we sought to blunt the adaptive increases in QA and zP by
restricting dietary protein intake [9]. The average value of
SNGFR of 38 nllmin in rats on a 6% protein diet was markedly
lower than the mean value of 63 nl/min obtained in the rats with
a similar degree of ablation but fed a standard, 24% protein,
diet. This blunting of the hyperfiltration response was the result
of a failure of QA (92 nI/mm) or P (32 mm Hg) to increase
despite the extensive loss of renal mass. Associated with this
near-normalization of SNGFR and its hemodynamic determi-
nants was a striking reduction in the structural abnormalities
observed in remnant glomeruli [9]. Additionally, protein excre-
tion remained at the same low rate as in normal rats, largely
because the defects described earlier in size- and charge-
selectivity were, for the most part, prevented (13].
Similar elevations in glomerular pressures and flows occur
not only in remnant kidneys following surgical ablation but in
other models of renal disease as well [17, 21—23]. Moreover, in
these models hyperfunctioning glomeruli eventually deteriorate
in the same manner as do remnant glomeruli in rats undergoing
extensive renal ablation. Studies by Azar et al in "post-salt"
hypertension [24] and by Dworkin and colleagues in "DOCA-
salt" hypertension [181 reveal a strong correlation between
glomerular pathology and gbomenilar capillary hypertension and
hyperperfusion; these findings lend additional support to the
concept that "adaptive" hemodynamic changes contribute to
the ultimate destruction of surviving glomeruli in renal diseases
of diverse cause. Further support for this view derives from the
observation that unilateral nephrectomy hastens the progres-
sion of glomerular sclerosis induced by a variety of maneuvers
including renal irradiation [25], injection of nephrotoxic serum
[26], and repeated administration of puromycin aminonucleo-
side [27]. Unilateral nephrectomy also hastens the development
of azotemia and renal histopathology in the NZB x NZW
mouse, an animal model of lupus erythematosus [28]. Presum-
ably, uninephrectomy adds to the hemodynamic burden of
glomeruli previously subjected to these various forms of injury.
Graded reductions in dietary protein intake have been shown
to prolong survival of young rats subjected to extensive renal
ablation [29, 30]. Protein restriction also retards the progression
of nephrotoxic serum nephritis in rats [31, 32] and the lupu s-like
nephropathy of the NZB x NZW mouse [33]. In the "DOCA-
salt" hypertensive rats studied in our laboratory, protein re-
striction was shown to limit the giomerular hemodynamic
changes and the associated glomerular structural abnormalities
and proteinuria as well [18]. On the other hand, accelerated
glomerular sclerosis occurs in uninephrectomized rats either
fed high-protein diets [34, 35] or induced to overeat by hypotha-
lamic injury [36].
Collectively, these findings support our view that hemody-
namic alterations are responsible for the early morphologic
derangements observed in subtotally nephrectomized rats fed a
standard diet. Other investigators have suggested that dietary
phosphorus restriction and thyroparathyroidectomy limit the
progression to uremia that occurs in rats with underlying renal
injury [37, 38]. The beneficial effect of these maneuvers orig-
inally was attributed to a reduction in circulating parathyroid
hormone levels and decreased deposition of calcium and phos-
phorus in the renal interstitium [37, 38]. Such changes are
unlikely to account for the protective effect of low protein
feeding, however. Dietary phosphorus content was comparable
in the normal (0.99%) and low-protein (0.70%) diets [9]; both
levels were well above the 0.04% used in the studies of
phosphorus restriction by Alfrey and coworkers [37, 38]. More
important, in the study by Hostetter et al, calcium phosphate
deposits were not demonstrable in the remnant renal tissue at
the conclusion of the study [9].
More recent studies by Alfrey and coworkers suggest that the
previously described beneficial effects of dietary phosphate
restriction and thyroparathyroidectomy are not related to pre-
vention of interstitial crystalline deposits or to suppression of
parathyroid hormone [39]. Indeed, parathyroidectomy alone
did not confer the same protective effect as was initially seen
with thyroparathyroidectomy. Of note, chronic low phosphate
feeding as well as thyroidectomy lead to reductions in GFR in
normal animals [40, 41]. In the studies of Alfrey and coworkers,
kidney weights were lower in animals given nephrotoxic serum
and followed either by severe phosphate restriction or thyropar-
athyroidectomy, relative to nephritic animals fed a normal diet
or with intact thyroid glands [38, 39]. These findings therefore
are consistent with the view that phosphate restriction and
thyroidectomy limit renal growth; perhaps these maneuvers
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also limit compensatory hemodynamic alterations. The possi-
bility thus exists that phosphate deprivation and thyroidectomy
are protective by virtue of their inhibition of hemodynamic
alterations in remnant glomeruli and not by any direct effect on
divalent ion metabolism.
Mechanisms of hemodynamically mediated glomerular injury
If hemodynamic alterations underlie the progressive sclerosis
of residual glomeruli, how do such physical alterations exert
their effects? The increased mean glomerular transcapillary
hydraulic pressure difference, zP, may injure the capillary
network by some process analogous to the effects of systemic
hypertension on arterioles; this mechanism presumably in-
volves mechanical disruption of normal vascular integrity. But
it seems unlikely that systemic hypertension per se adequately
accounts for the progressive glomerulopathy that occurs with
renal ablation. For example, Purkerson, Hoffsten, and Klahr
reported that rats subjected to only partial infarction of one
kidney developed arterial hypertension, with a mean arterial
pressure of 153 mm Hg [12]. Despite the hypertension, in these
rats with only a small portion of the renal mass removed,
glomerular morphologic abnormalities did not develop. Using
other animals subjected to a far greater degree of renal ablation
(comparable to that employed by Hostetter et al [9]), Purkerson
and colleagues were able to reduce systemic blood pressure to
near-normal levels with antihypertensive drugs, yet significant
glomerular damage ensued [12]. These various findings prompt-
ed these authors to suggest that uremia or a critical reduction in
renal mass was necessary for development of the progressive
glomerular lesion [12]. In addition, the pattern of intrarenal
resistances and, consequently, of glomerular pressures and
flows observed in subtotally nephrectomized rats differs from
that described in several other animal models of chronic hyper-
tension that involve no reduction in renal mass [42, 43]. Such
hypertensive rats display no increase in glomerular capillary
hydraulic pressures despite systemic arterial hypertension;
moreover, glomerular plasma flow rates tend to be reduced, not
elevated, because intrarenal resistances typically are increased.
In contrast, rats with partial renal ablation exhibit reduced
afferent and efferent arteriolar resistances in the presence of
mild systemic hypertension, thereby favoring increased glomer-
ular capillary hydraulic pressures and plasma flows [91. It is
interesting to speculate that this failure to autoregulate glorneru-
lar capillary hydraulic pressure and plasma flow may underlie
the hemodynamic abnormality of pathogenetic importance in
this model. In this regard, Azar et at have suggested that
reductions in intrarenal resistances might play a key role in the
glomerular damage that arises with unilateral nephrectomy in
the so-called "post-salt" hypertensive model [241. Also, in the
"DOCA-salt" model of hypertension, Dworkin and coworkers
recently demonstrated that elevations in QA and P correlate
closely with structural damage [18]. Furthermore, as I already
have stated, they showed that these hemodynamic changes and
their attendant morphologic alterations could be reversed with
low-protein feeding. Finally, Feld and colleagues have speculat-
ed that a relative inability of the juxtamedullary nephrons to
autoregulate is somehow responsible for the greater glomerular
injury that this nephron population suffers in the spontaneously
hypertensive rat [44].
Whereas systemic arterial hypertension is not a factor com-
mon to all the models considered thus far, intrarenal hyperten-
sion (increased iW) and hyperperfusion (increased QA) clearly
are. As shown in Figure 1, their combined effects lead to an
increased transcapillary flux not only of ultrafiltrate (increased
SNGFR) but of macromolecules as well (increased albumin-
uria). Associated changes in the intrinsic permselective proper-
ties of the glomerular wall also result in an increased flux of
macromolecules through the wall. This increased transglomeru-
lar traffic of plasma proteins ultimately might injure a compo-
nent or components of the glomerulus [27, 45]. Indeed, studies
of ferritin localization demonstrate a greatly increased deposi-
tion of this electron-dense protein in the mesangial region of
glomeruli following surgical ablation as compared to control
animals [13]. It is therefore likely that an overloading of this
region might be a general mechanism for increasing matrix
deposition, the forerunner of glomerular sclerosis [27, 45]. The
resulting loss of glomerular units imposes a further hemody-
namic burden on less affected glomeruli, and leads to their
eventual destruction as well.
Evidence for hemodynamic factors in the initiation and
progression of diabetic glomerulopathy
In patients with diabetes mellitus, glomerular hyperfunction
occurs prior to loss of nephron units and thus may contribute to
the initiation as well as to the progression of the glomerulo-
pathy commonly encountered in this metabolic disorder [19].
Several investigators have documented overt hyperfiltration in
children and young adults with juvenile-onset diabetes [46, 471.
Hostetter et al have shown that similar glomerular hyperfiltra-
tion in the rat made diabetic with streptozotocin is due, as is the
case with renal ablation, to intrarenal vasodilation and sus-
tained elevations in QA and zP [17].
The potential importance of intrarenal hemodynamic alter-
ations in the pathogenesis of diabetic glomerulopathy also
receives support from a variety of observations over the last
decade. Steffes, Brown, and Mauer compared the progression
of mesangial expansion in rats with streptozotocin-induced
diabetes and with or without unilateral nephrectomy [48].
Mesangial deposition of circulating plasma proteins and mesan-
gial widening were more marked in diabetic animals with
superimposed unilateral nephrectomy. Although intrarenal he-
modynamics were not measured in this study, we can reason-
ably assume that values for SNGFR, QA and zP were elevated
above normal in the remnant kidneys of these diabetic rats as a
result of contralateral nephrectomy. Further studies by these
same investigators using the streptozotocin model of diabetes in
rats have defined the effects on the diabetic glomerular lesions
of a unilateral renal artery clip, the so-called "two-kidney
Goldblatt" hypertensive model [49]. Diabetic as well as normal
animals became hypertensive with this maneuver. In unclipped,
normotensive diabetic rats, characteristic glomerular lesions
developed equally in both kidneys. In diabetic rats with a uni-
lateral renal artery clip, however, a distinct asymmetry of these
glomerular lesions was found: the unclipped kidneys, in which
glorneruli were likely to be exposed to elevations in QA and P,
showed more severe glomerular injury than did the kidneys of
normotensive diabetic rats. Moreover, the clipped kidneys in
the same diabetic animals had less glomerular injury than did
Fig. 1. Role of sustained increments in
glomerular pressures and flows in the
initiation and progression of glomerular
sclerosis.
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the kidneys of normotensive diabetic rats. Th!s disparity be-
tween the two kidneys was present despite identical proce-
dures for producing diabetes in the two diabetic groups, and
despite equivalent degrees of hyperglycemia in normotensive
and hypertensive animals. These studies clearly indicate that
alterations in intrarenal hemodynamics can influence the
glomerular structural changes characteristic of experimental
diabetes. The clinical counterpart of these findings has also
been reported from autopsy findings in a patient with diabetes
and unilateral renal artery stenosis [50]. Kimmelstiel-Wilson
lesions were confined to the kidney with the patent renal artery;
its contralateral partner with the tight stenosis exhibited little
glomerular pathology. Finally, diabetic patients with essential
hypertension typically progress more rapidly to renal insuffi-
ciency than do normotensive diabetic patients, and recent
studies by Mogensen indicate that treatment of the hyperten-
sion in these patients slows this accelerated rate of progression
[51].
Taken together, these experimental studies and clinical ob-
servations strongly suggest that renal hemodynamics exert a
key influence on the initiation and rate of progression of
diabetic glomerulopathy. Indeed, the process leading to overt
diabetic glomerulopathy is consistent with the general principle
that sustained elevations in QA and P are ultintately detrimen-
tal to the glomerulus. Such elevations in QA and zP may result
from hyperglycemia-induced extracellular fluid volume expan-
sion and/or from altered glucoregulatory or vasoregulatory
hormone action. Whatever their origin, the hemodynamic alter-
ations lead to increased SNGFR which, in turn, augments the
glomerular transcapillary convective flux of plasma proteins
(Fig. 1). Long-term elevations in glomerular pressures and
flows also would be expected to alter the permselective proper-
ties of the glomerulus and further increase protein filtration.
Such increased transglomerular traffic of plasma proteins leads
to their accumulation in the mesangium and thereby stimulates
proliferation of mesangial cells and matrix and eventuates in
glomerular sclerosis. Thus, the renal hemodynamic alterations
associated with less than optimal metabolic control of diabetes
could themselves initiate glomerular sclerosis. With loss of the
function of sclerotic glomeruli, less severely afflicted glomeruli
would undergo compensatory hyperfiltration, thereby closing a
positive feedback loop that promotes progressive glomerular
injury and eventual loss of renal function.
The progressive nature of human renal disease
Nephrologists know all too well that the vast majority of
patients with glomerular filtration rates below approximately 25
ml/min eventually require dialysis or transplantation, regardless
of the original cause of reduced renal function. Time plots of the
reciprocal of serum creatinine concentration clearly testify to
the steady deterioration of nephron function; this decline tends
to occur at rates more characteristic of a given patient than of a
particular underlying disease [52, 53]. In some patients, the
disease responsible for the initial renal injury remains active
throughout the course to end-stage renal failure; more often,
however, renal failure progresses even when a well-defined
initiating process either has remitted spontaneously or has been
controlled therapeutically. For example, as Baldwin discussed
in a recent Nephrology Forum [54], renal disease following
acute poststreptococcal glomerulonephritis can progress in the
absence of continued immunologic injury to the kidney. Like-
wise, as with the woman considered at this conference, patients
with bilateral cortical necrosis often enjoy a temporary period
of recovery prior to the progression of end-stage renal insuffi-
ciency [4]. In these patients, glomerular sclerosis eventually
destroys the surviving juxtamedullary units. This pattern of
destruction is strikingly reminiscent of the preferential involve-
ment of deeper glomeruli in patients with various forms of renal
disease, especially the entity of focal and segmental glomerular
sclerosis [55]. Presumably, the higher ambient values for
SNGFR in deeper glomeruli which, in all likelihood, are driven
by higher local pressures and flows, make them more vulnera-
ble than are more superficial units to the further hemodynamic
stresses that occur with widespread renal injury [56]. Patients
with vesicoureteral reflux also exhibit a progressive glomerulo-
pathy, despite the absence of hypertension or active urinary
tract infection, and often despite surgical correction of the
reflux [57]. The hemodynamic and other factors thought to
contribute to glomerular sclerosis in reflux nephropathy have
been considered in detail by Cotran at another recent Nephrolo-
gy Forum [58]. Glomerulosclerosis, progressive azotemia, and
proteinuria also are common findings in patients with long-
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standing abuse of analgesic drugs [591, sickle cell nephropathy
[60], segmental hypoplasia [61], congenital nephrotic syndrome
[62], massive obesity [63]. and, of course. type-I (juvenile
onset) diabetes mellitus [17. 19].
Is there a critical number of functioning nephrons below
which hemodynamically mediated glomerular injury is inevita-
ble? No firm conclusion is possible yet. When, however, the
number of nephrons is reduced by more than 50%, as in
oligomeganephronia, remnant glomeruli initially undergo func-
tional and structural hypertrophy, which is followed by protein-
uria, glomerular sclerosis, and progressive renal failure [61].
Moreover, evidence has been amassed recently by Kiprov,
Colvin, and McCluskey suggesting that unilateral renal agenesis
in humans predisposes to focal and segmental glomerular
sclerosis and even to end-stage renal failure [64]. Unfortunate-
ly, there has been little systematic, long-term follow-up of
children and adults who have undergone surgical ncphrectomy
for grade-I renal cell carcinoma, trauma, or organ donation
such studies clearly are needed to evaluate this issue. I will
describe our preliminary findings in follow-up of kidney donors
during the question-and-answer period at the end of my discus-
sion. Other, related questions deserve attention: (1) Is the entity
that we routinely call "chronic transplant rejection" a form of
hemodynamically mediated renal injury in allograft recipients?
In many instances, graft function deteriorates over several
years, usually in association with proteinuria, despite the
absence of clinically apparent episodes of acute rejection. (2) Is
there a spectrum of oligonephron states that spans the extremes
of marked hypoplasia, on the one hand, and normal nephron
number on the other? (3) Is the propensity for young males to be
more seriously affected than are females in certain renal dis-
eases (such as hereditary nephritis, IgA nephropathy. and focal
and segmental glomerular sclerosis) due in part to the renotro-
phic effects of androgenic hormones? In rats, the magnitude of
proteinuria following unilateral nephrectomy is greater in males
than in females [34], as is the incidence of spontaneous glomer-
ular sclerosis associated with aging [651. (4) Does the hyperfil-
tration of pregnancy contribute to the deterioration of renal
function seen in some gravidas with underlying diabetes, lupus
nephritis, and other forms of previously mild renal insufficien-
cy? Likewise, since hyperfiltration with repeated pregnancies
can have a cumulative effect, are multiparas more prone to
hypertension and intrinsic renal disease than are nulliparas? (5)
Finally, are some individuals predestined to develop renal
insufficiency because of chronic renal vasodilation and sus-
tained elevations in intrarenal pressures and flows that are
"physiologic" rather than the consequence of a disease proc-
ess? For example, we recently have expressed concern that the
high-protein diet characteristic of modern Western society
might itself induce chronic renal hyperperfusion and thereby
predispose to progressive glomerular sclerosis and age-related
declines in GFR. In brief, one can argue that a fundamental
mismatch exists between the design characteristics of the
human kidney and the functional burden imposed by the ad
libitum eating habits now regarded as normal in our society.
Sustained excesses of protein in the diet impose corresponding-
ly sustained increases in renal blood flow and GFR. and thus
require that the "reserve" glomeruli of the outer cortex be
utilized more or less continuously. This pattern of continuous
hyperfiltration implies that time-averaged glomerular pressures
and flows are higher than values that would be expected to
prevail with lower protein intakes, as when feeding is intermit-
tent; in turn, the resulting "intrarenal hypertension" could well
predispose to age-associated progressive glomerular sclerosis
and declining renal blood flow and GFR.
In normal individuals, the decrease in GFR between the third
and ninth decades is approximately 40%. This decline may he
the biologic price of renal hyperperfusion associated with ad
libitum feeding, and might be tolerable in the absence of
diabetes, acquired renal disease, or surgical loss of renal mass.
An unrestricted protein diet, however, could exaggerate the
increments in glomerular pressures and flows associated with
an episode of nephron loss, and could accelerate the develop-
ment of glomerular sclerosis and lead to more rapid loss of renal
function.
Current treatment modalities for patients with chronic renal
insufficiency unfortunately do little to interrupt the hemody-
namic mechanisms of progressive renal failure. If my hypothe-
sis is correct, we will need therapies aimed at preventing
excessive glomerular pressures and flows to check the relent-
less progression of clinical renal disease. An obvious first step,
as suggested by Addis more than three decades ago [66], might
be a reduction of protein intake, implemented early in the
course of intrinsic renal disease. Indeed, Maschio et al [671 and
(iiordano [68, 69] recently have argued that the rate of progres-
sion can be effectively retarded in a variety of renal disorders by
prolonged control of dietary protein intake. Likewise, early
institution of rigid metabolic control by continuous insulin
infusion or other means in patients with juvenile-onset diabetes
could prove effective in preventing glomerulopathy in this high-
risk population [70], Given these perspectives, I think we have
reason to be optimistic about the clinical and therapeutic
possibilities that lie ahead.
Questions and answers
DR. JEROME P. KASSIRER: Your hypothesis to explain pro-
gressive renal damage is fresh, provocative, and exciting. If we
are going to begin widely recommending protein restriction to
prevent progressive renal failure, it would he of considerable
advantage to understand the mechanisms by which the damage
takes place. What is known about the precise mechanisms that
cause the increase in single-nephron GFR in preserved glomer-
uli when other glomeruli are damaged? Second, how does
protein intake affect the GFR?
DR. BRENNER: 1 guess I would put it a little differently.
Whether we understand how protein restriction works, I see
little reason not to recommend this dietary modification to
patients with renal disease, and a few studies that have been
done thus far support this belief [67—70]. These and other
studies suggest that by reducing dietary protein intake to
approximately 0.7 g/kg/day we can achieve considerable ame-
lioration, if not arrest, of progression of the disease. Based on
these preliminary findings, I would also recommend that people
who undergo nephrectomy restrict their protein intake to a
similar extent.
Not much is known about the mechanisms of this ameliora-
tion. We know that there is a hyperemic renal response to a
protein meal, and we know that the response can he duplicated
with certain amino acids, but not with urea. If one infuses
glucagon or growth hormone, hemodynamic changes that occur
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with protein or amino acids can be duplicated. And, as you
know, both hormones are released when amino acids are
infused or when a high-protein meal is ingested.
DR. JORDAN J. COHEN: Is there any evidence that these
lesions can be either stabilized or reversed?
DR. BRENNER: You can certainly expect stabilization if you
start with serum creatinine levels below about 6 mg/dl. Several
investigators have shown stabilization with essential amino
acids and their nitrogen-free analogues in patients with
advanced renal insufficiency [71, 72]. Maschio and coworkers
have been successful in arresting progression when the pa-
tients' serum creatinines are below 3 mg/dl [671; it is harder to
arrest progression when serum creatinine values exceed 6
mg/dl, but a halt to the progression has occurred in some of
these patients.
DR. NIcoLAos E. MADJAS: Can you prevent the deleterious
effect of a high-protein diet in the remnant kidney by keeping
the renal artery clipped?
DR. BRENNER: Dr. Lance Dworkin in our laboratory tried
unsuccessfully to do this in our renal ablation model. He found
it extremely difficult to gauge the constriction when renal mass
is reduced so markedly. Furthermore, I don't see this as a
practical clinical approach and therefore we have no plans to
pursue this direction experimentally. Pharmacologic approach-
es to reducing renal perfusion seem more promising, perhaps
involving long-term diuretic therapy or the use of prostaglandin
synthetase inhibitors.
DR. MADIAS: Is there any evidence that chronic renal vasodi-
lation induced by pharmacologic manipulation leads to glomer-
ular sclerosis?
DR. BRENNER: I don't believe that such information is
available.
DR. GEETHA NARAYAN (Renal Fellow, NEMC): If you
attribute renal damage in juvenile-onset diabetics to modest
elevations of blood glucose, wouldn't you expect to see renal
damage more commonly in adult-onset diabetics who have only
modest evaluations of blood glucose most of the time?
DR. BRENNER: Hyperfiltration has not been a consistent
finding in adults with type-Il diabetes, for reasons not entirely
clear, at least to me. There may be something different about
renal vascular reactivity in patients with juvenile-onset diabetes
that favors the development of renal hyperperfusion and hyper-
filtration. Whatever the mechanisms involved, the risk of
hyperfiltration exists in the diabetic child, and so does the risk
of glomerulopathy; in the adult we typically don't see either
effect.
DR. JOHN T. HARRINGTON: Are the rats that received a low-
protein diet in nitrogen balance at that level of intake?
DR. BRENNER: We haven't had a chance to quantitate nitro-
gen balance in our rats, but they look well and are active in the
cage.
DR. HARRINGTON: All the experimental data you have shown
us today comes from rats. Are there other animal models in
different species in which glomerular sclerosis can be provoked
by protein feeding?
DR. BRENNER: Very little work has been done. Several
researchers, however, have reported progressive glomerulo-
sclerosis in aging dogs [73—781.
DR. COHEN: Gradually progressive renal damage can occur in
obese patients who have undergone intestinal bypass. Does the
initiation of glomerular damage in that setting fit into your
hypothesis?
DR. BRENNER: Once the patient has extensive glomerular
damage, I think it unlikely that the process can be arrested. We
know from studies in rats with genetic obesity as well as from
studies in rats with severe overeating induced by hypothalamic
injury that a progressive glomerulopathy is the rule. In both
circumstances the glomerular lesions can be ameliorated by
restricting food intake [79]. Equivalent studies have been
performed in humans, and most of the reported patients with
this progressive glomerulopathy have been massively obese;
dietary restriction may slow the progression in those patients.
DR. COHEN: You alluded briefly to the observation that
phosphate restriction also tends to forestall the development of
progressive renal damage. How do you link these findings to
your present hypothesis?
DR. BRENNER: We have to scrutinize the papers incriminat-
ing phosphate as the culprit in progressive glomerulosclerosis.
Alfrey originally showed that phosphate restriction can lead to
some arrest of progression. Thyroparathyroidectomy did the
same; but when he did selective parathyroidectomy, protection
was no longer achieved. Recently he and his colleagues have
claimed that thyroidectomy alone confers protection [39]. The
protection previously claimed for phosphate restriction thus is
now in doubt. Moreover, in a recently published clinical study
in which phosphate intake was selectively reduced in patients
with various forms of renal disease, no evidence of protection
was obtained [801. Phosphate-binding gels were used, diet was
not restricted, and the progressive decline in renal function was
not ameliorated. I think the protein, not the phosphate, is the
important factor.
DR. HARRINGTON: Dr. Brenner, I'd like to turn from protein
intake to protein excretion. Dr. Beldon Idelson and I and our
colleagues have reported that all our patients with nephrotic
syndrome whose protein excretion fell to between 150 mg/day
and 2.0 g/day maintained normal renal function for as long as 15
years [811. Others have made similar observations [82]. We had
no ready explanation for this observation, but it seems to me to
be consistent with your hypothesis.
DR. BRENNER: Do you have any information regarding the
incidence of hypertension in these patients?
DR. HARRINGTON: We did not analyze the blood pressures in
our published report, but that information probably could be
obtained from reviewing the patients' charts.
DR. MADIAS: I would suspect that the presence of renal
nerves is not required for the vasodilation that develops with
ingestion of a high-protein diet. Has this been tested?
DR. BRENNER: To my knowledge, this type of experiment has
not been reported. It is interesting though that patients with
familial dysautonomia develop a characteristic glomerular le-
sion. Do you know what it is?
DR. KASSIRER: Focal sclerosis.
Da. BRENNER: Exactly. One could speculate that the vasodi-
lation leads to sustained high glomerular flows and pressure,
thereby predisposing the patient to progressive glomerulo-
sclerosis. Some of these patients progress to end-stage renal
disease [83].
DR. COHEN: What has been your experience in the follow-up
of kidney transplant donors?
DR. BRENNER: Drs. Robert C. Goldszer, Raymond Hakim,
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and I have contacted a number of adults who donated kidneys
in the Brigham program 10 or more years ago [841. To date
we've studied 25 individuals (13 men and 12 women) with a
mean age of 60 years. Of the 19 people who donated kidneys 10
to 14 years ago, 7 are hypertensive (diastolic blood pressure
greater than 90 mm Hg), and urine protein excretion averages
130 19 SEM mg/day. None was hypertensive at the time of
donation, and protein excretion at that time was always less
than 50 mg/day. Six other individuals donated a kidney more
than 15 years ago, and of these, 3 are hypertensive; daily
protein excretion averages 366 127 mg/day. Similar findings
have been reported by others [851. Clearly, similar follow-up
studies are required in other centers for us to obtain a fair and
accurate analysis of this potential problem.
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